Stay updated on Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.

Latest updates to the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices about funding lapse and Revision: v3.4.1 on the history page; these are minor history/operational updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding/operating status notice banner and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates include a glossary display option, color-coding legends for changes, and updated revision/version text. These changes are cosmetic and do not modify core study data or content.SummaryDifference0.5%

- Check35 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed from the page history display.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.3.3 appears in the page header. The footer updates remove HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.